MICHAEL MACALUSO
CIK 1096423 · CEO · last filed 2022-01-04
MICHAEL MACALUSO is a CEO who has filed 21 SEC Form 4 insider transactions across 2 companies since 2012. The most recent filing shows the insider had shares withheld for taxes covering $39.0K of AMPE on Jan 4, 2022. Current disclosed insider exposure totals $447.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$447.4K
2
21
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Ampio Pharmaceuticals, Inc. (AMPE) Delisted | CEO | 2,624,882 | $0.18 | $480.6K | $0 | 13 | 2022-01-04 |
| AYTU | Director | 208,079 | $2.15 | $447.4K | $0 | 4 | 2021-04-16 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-04 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Tax (F) | −68,400 | -$39.0K | EDGAR |
| 2021-10-28 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Tax (F) | −43,470 | -$71.3K | EDGAR |
| 2021-10-13 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Grant (A) | +950,000 | $0 | EDGAR |
| 2021-04-16 | AYTU | Grant (A) | +187,804 | $0 | EDGAR |
| 2020-12-21 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-06 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Mixed | — | $0 | EDGAR |
| 2020-06-12 | AYTU | Grant (A) | — | $0 | EDGAR |
| 2020-01-14 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-10-26 | AYTU | Grant (A) | +200,000 | $0 | EDGAR |
| 2017-11-09 | AYTU | Grant (A) | +50,000 | $0 | EDGAR |